S&P 500 Futures
(0.26%) 5 104.50 points
Dow Jones Futures
(0.63%) 38 624 points
Nasdaq Futures
(0.51%) 17 740 points
Oil
(0.19%) $79.10
Gas
(-0.79%) $2.02
Gold
(0.02%) $2 310.00
Silver
(0.10%) $26.86
Platinum
(0.41%) $966.50
USD/EUR
(-0.06%) $0.932
USD/NOK
(-0.05%) $10.99
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.87%) $91.93

リアルタイムの更新: Kwang Dong Pharmaceutical [009290.KS]

取引所: KSC セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
最終更新日時3 5月 2024 @ 15:19

0.15% KRW 6 890.00

Live Chart Being Loaded With Signals

Commentary (3 5月 2024 @ 15:19):

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents...

Stats
本日の出来高 65 384.00
平均出来高 536 702
時価総額 276.16B
EPS KRW138.05 ( 2024-03-14 )
次の収益日 ( KRW0 ) 2024-05-10
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW4.69 (0.07%)

ボリューム 相関

長: 0.11 (neutral)
短: 0.30 (neutral)
Signal:(65.654) Neutral

Kwang Dong Pharmaceutical 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Kwang Dong Pharmaceutical 相関 - 通貨/商品

The country flag -0.33
( neutral )
The country flag -0.26
( neutral )
The country flag -0.33
( neutral )
The country flag 0.18
( neutral )
The country flag 0.16
( neutral )

Kwang Dong Pharmaceutical 財務諸表

Annual 2023
収益: KRW1 514.45B
総利益: KRW295.12B (19.49 %)
EPS: KRW913.39
FY 2023
収益: KRW1 514.45B
総利益: KRW295.12B (19.49 %)
EPS: KRW913.39
FY 2022
収益: KRW1 431.55B
総利益: KRW282.05B (19.70 %)
EPS: KRW588.45
FY 2021
収益: KRW1 338.18B
総利益: KRW274.25B (20.49 %)
EPS: KRW592.66

Financial Reports:

No articles found.

Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Co., Ltd. operates as a human healthcare provider in South Korea. It develops and sells OTC drugs in the areas of antitussive expectorants, ophthalmic, liver disease agents, mineral preparations, vitamins, circulating system, and nutritious tonics; and ETC drugs in the areas of oral hypoglycemic agents, anti-arteriosclerotic agents, metabolic drugs, vitamins, digestive organ agents, circulating systems, immunosuppressants, obesity drugs, urinary genital and anal drugs, appetite suppressants, neuropsychiatric solvents, antispasmodics, antitussive expectorants, anti-vertigo drugs, antivirals agents, anti-malignant-tumor agents, and vasodilator, as well as antiepileptic, antihistaminic, antipyretic, analgesic, and anti-inflammatory agents. The company also provides general supplements, OTC drinks, consumer drinks, functional drinks, and traditional health foods. In addition, it engages in the operation of hospitals; and the retail and wholesale of products through discount stores, TV home shopping, and Internet shopping malls. Further, the company operates as a MRO total service provider for the raw/intermediate materials and consumables under various business models, such as the construction purchase service and overseas local purchase service. Kwang Dong Pharmaceutical Co., Ltd. was founded in 1963 and is based in Seoul, South Korea.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。